Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Aleniglipron, developed by Structure Therapeutics, has reported strong Phase 2 weight-loss results, putting it firmly in the spotlight of the rapidly expanding obesity treatment market
Improve sperm health and increase chances of conception naturally
The loss of compounded GLP-1s is challenging, but its an opportunity for providers to step in and advocate for their patients and refer appropriately when the Bariatric Center is the best option, says Dr
Current Evidence and Clinical Trial Findings Phase 2 data published in the NEJM (2023) showed dose-dependent body weight reductions with retatrutide over 48 weeks, with gastrointestinal side effects being the most commonly reported
SGLT2 inhibitors (Jardiance, Farxiga) help the kidneys by reducing glucose and sodium reabsorption in the kidneys, lowering blood pressure, and reducing protein leakage in urine
